Adeptmind uses Generative AI to solve complex retail challenges across merchandising, personalization, and product discovery. The platform enhances e-commerce performance by optimizing merchandising workflows and improving customer intent capture across digital touchpoints. This results in increased ROAS and more effective high-intent digital discovery for retailers.

AirWorks develops AI-powered software that automates the generation of precise linework from aerial data, enabling rapid production of high-quality maps for civil engineering and surveying projects. This technology significantly reduces project turnaround times to an average of four days, allowing firms to take on more work and improve their bidding success.

Antiverse utilizes machine learning and advanced cell line engineering to design target-specific antibody libraries for challenging drug targets, including G-protein coupled receptors and ion channels. The platform accelerates the antibody discovery process, enabling the development of functional therapeutics within six months, addressing the lengthy timelines typically associated with traditional drug development methods.

The startup operates a drug discovery platform focused on developing therapies for antimicrobial resistance by targeting multiple pathways in disease modulation. This approach enhances the efficacy of new medicines while minimizing risks during the discovery and development phases, ultimately improving treatment outcomes for chronic ailments.

Ava Robotics develops autonomous telepresence robots that facilitate remote collaboration, security, and healthcare services in workplace environments. Their technology enables real-time interaction and monitoring, enhancing productivity and safety while minimizing the need for physical presence.

BioIntelligence Technologies develops the BioIntelligence Analytics Solution™, which includes the BiOptic+™ spectrometer for real-time inline measurements and the BioAnalyst™ software for comprehensive process analysis. This technology enables bioprocess manufacturers to reduce losses from deviations and contaminations while increasing conversion yields and minimizing batch-to-batch variability.

Clairways provides smart lung monitoring technology that utilizes real-time respiratory data analytics to enhance patient safety and improve trial accuracy in pharmaceutical clinical trials. The technology enables precise monitoring of lung function across diverse patient populations, facilitating timely interventions and ensuring reliable trial outcomes.

Copernic designs novel heterogeneous catalysts for zero-carbon fuels and chemicals, leveraging scientific computing tools to accelerate development. The company focuses initially on reducing the cost of zero-carbon ammonia production for fertilizers and maritime energy applications. Their solutions are engineered to be economic, rapidly scaleable, and compatible with existing chemical industry infrastructure.

The startup develops a digital health application that compiles a database of medications and their side effects, providing features such as pill reminders and prescription refill notifications. This application helps patients manage their medication schedules and stay informed about FDA updates, reducing the risk of adverse drug reactions.

Deeplite provides AI optimization software that enhances the performance of deep neural networks by reducing their size and energy consumption. This technology enables faster inference times, making AI applications more efficient and cost-effective for various industries.

Dyania Health utilizes natural language processing to automate the review of electronic medical records (EMRs), enabling rapid pre-screening of patients for clinical trials with over 95% accuracy. This technology significantly reduces the time required for medical professionals to identify eligible candidates, ensuring timely access to critical treatments and improving patient outcomes.

Encora Therapeutics is developing a wearable device that utilizes real-time signal processing to deliver personalized vibro-tactile stimulation to the wrist, effectively counteracting hand tremors associated with neurodegenerative movement disorders like Parkinson's disease. This non-invasive technology not only alleviates tremors but also enables continuous monitoring of disease progression for improved patient care.

Entri is a vernacular language learning platform that offers over 600 courses in eight Indian languages, focusing on skill development and exam preparation for various competitive tests. By providing expert guidance, practice tests, and tailored curriculum, Entri helps users enhance their employability and achieve their career goals.

Fourier Health uses AI and clinician oversight to ingest multi-format clinical data, transforming disparate records into standardized, actionable summaries. The platform ensures accuracy through source linking and clinician review while offering outputs customized for specific medical specialties and use cases. This process reduces administrative burden, accelerates clinical decision-making, and can improve revenue cycle management metrics like RAF scoring.

Ilios develops multi-functional small molecules that target protein misfolding, oxidative stress, and neuroinflammation to combat neurodegenerative diseases like Alzheimer's and ALS-FTD. Their chemistry platform merges bioactive pharmacophores with glutathione and fatty acids to create compounds that effectively penetrate the brain and address the underlying mechanisms of these disorders.

Juniper Genomics employs whole genome and transcriptome sequencing along with proprietary data analysis to enhance embryo selection in in vitro fertilization (IVF). By providing personalized insights based on comprehensive genetic data, the company increases the likelihood of successful embryo transfers, thereby improving IVF outcomes.

Marigold provides an anonymous, mobile community where individuals facing mental health or substance use challenges can access 24/7 peer‑to‑peer support groups and optional one‑on‑one coaching from certified Peer Recovery Coaches. The platform uses NLP‑driven analytics to surface high‑need topics and integrates with users' existing care teams and insurance plans, extending support beyond regular clinical hours.

ODAIA provides an AI‑driven platform that unifies pharmaceutical commercial data and delivers predictive analytics to identify high‑potential healthcare professionals. Its dynamic, explainable machine‑learning models generate real‑time HCP segmentation and forecast prescription trends, giving sales reps prioritized call lists and managers actionable dashboards for coaching and strategy adjustments.

PathAI develops AI-powered pathology technology that enhances diagnostic accuracy by providing pathologists with advanced image management and case management tools. The platform improves patient outcomes by streamlining laboratory workflows and facilitating biomarker discovery for drug development.

Perceptive designs and manufactures a handheld intraoral scanner utilizing optical coherence tomography (OCT) technology to capture 3D volumetric data with over 90% accuracy for caries detection, eliminating the need for ionizing radiation. The company is also developing a dental robotics system aimed at completing restorative procedures in 15 minutes, significantly reducing the time and complexity of traditional methods.

Persist AI accelerates drug formulation discovery by integrating an AI platform with high-throughput robotics in a cloud lab environment. This system allows scientists to design experiments remotely, which are then executed automatically to rapidly screen and predict formulations matching a target product profile. The company supports the entire process from initial discovery through to commercial cGMP manufacturing and analytical testing.

Sensorum Health is a healthcare services platform that utilizes 24/7 passive monitoring and a "nurse-in-the-loop" model to identify acute health declines in seniors with chronic conditions. By facilitating timely clinical interventions, the platform aims to prevent avoidable hospitalizations and enhance patient outcomes while maintaining privacy through non-intrusive data collection methods.

Starling Medical develops UrinDx™, a home-based urine monitoring device that provides real-time health insights to detect urinary tract infections (UTIs) early. This technology enables proactive health management and connects users with clinical care, reducing the risk of recurrent UTIs and hospitalizations.

STRM.BIO utilizes extracellular vesicles to deliver gene therapy, enhancing the efficiency and safety of treatment for patients with rare diseases. This approach aims to simplify the administration of gene therapies, making them more practical and accessible for global patient populations.